PBI-MST-01 (NCT04541108) Substudy MSD-03: Intratumoral Microdosing of Pembrolizumab Alone and With MK-0482 or MK-4830 in HNSCC or STS

Clinical trial NCT06413095 · COMPLETED

Trial details

NCT number: NCT06413095
Sponsor: Presage Biosciences
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Head and Neck Squamous Cell Carcinoma Soft Tissue Sarcoma

Start date: 2022-06-01
Primary completion: 2023-06-22
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.